Contribution of the putative heparan sulfate-binding motif BBXB of RANTES to transendothelial migration
- PMID: 12213786
- DOI: 10.1093/glycob/cwf069
Contribution of the putative heparan sulfate-binding motif BBXB of RANTES to transendothelial migration
Abstract
The chemokines are a family of small chemoattractant proteins that have a range of functions, including activation and promotion of vectorial migration of leukocytes. Regulation on activation, normal T cell expressed and secreted (RANTES; CCL5), a member of the CC-chemokine subfamily, has been implicated in a variety of immune responses. In addition to the interaction of CC-chemokines with their cognate cell-surface receptors, it is known that they also bind to glycosaminoglycans (GAGs), including heparan sulfate. This potential for binding to GAG components of proteoglycans on the cell surface or within the extracellular matrix might allow formation of the stable chemokine concentration gradients necessary for leukocyte chemotaxis. In this study, we created a panel of mutant RANTES molecules containing neutral amino acid substitutions within putative, basic GAG-binding domains. Despite showing reduced binding to GAGs, it was found that each mutant containing a single amino acid substitution induced a similar leukocyte chemotactic response within a concentration gradient generated by free solute diffusion. However, we found that the mutant K45A had a significantly reduced potential to stimulate chemotaxis across a monolayer of microvascular endothelial cells. Significantly, this mutant bound to the CCR5 receptor and showed a potential to mobilize Ca(2+) with an affinity similar to the wild-type protein. These results show that the interaction between RANTES and GAGs is not necessary for specific receptor engagement, signal transduction, or leukocyte migration. However, this interaction is required for the induction of efficient chemotaxis through the extracellular matrix between confluent endothelial cells.
Similar articles
-
Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis.Biochem J. 2001 Sep 15;358(Pt 3):737-45. doi: 10.1042/0264-6021:3580737. Biochem J. 2001. PMID: 11535134 Free PMC article.
-
A biophysical insight into the RANTES-glycosaminoglycan interaction.Biochim Biophys Acta. 2009 Apr;1794(4):577-82. doi: 10.1016/j.bbapap.2009.01.001. Biochim Biophys Acta. 2009. PMID: 19455751
-
The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity.J Biol Chem. 2001 Apr 6;276(14):10620-6. doi: 10.1074/jbc.M010867200. Epub 2000 Dec 14. J Biol Chem. 2001. PMID: 11116158
-
Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.Front Immunol. 2020 Mar 31;11:483. doi: 10.3389/fimmu.2020.00483. eCollection 2020. Front Immunol. 2020. PMID: 32296423 Free PMC article. Review.
-
Angiogenic properties of the chemokine RANTES/CCL5.Biochem Soc Trans. 2011 Dec;39(6):1649-53. doi: 10.1042/BST20110651. Biochem Soc Trans. 2011. PMID: 22103502 Review.
Cited by
-
G protein-coupled receptors in rheumatology.Nat Rev Rheumatol. 2014 Jul;10(7):429-36. doi: 10.1038/nrrheum.2014.62. Epub 2014 May 6. Nat Rev Rheumatol. 2014. PMID: 24798574 Review.
-
Novel Anti-Inflammatory Peptides Based on Chemokine-Glycosaminoglycan Interactions Reduce Leukocyte Migration and Disease Severity in a Model of Rheumatoid Arthritis.J Immunol. 2018 May 1;200(9):3201-3217. doi: 10.4049/jimmunol.1701187. Epub 2018 Mar 23. J Immunol. 2018. PMID: 29572348 Free PMC article.
-
A C-terminal CXCL8 peptide based on chemokine-glycosaminoglycan interactions reduces neutrophil adhesion and migration during inflammation.Immunology. 2019 Jun;157(2):173-184. doi: 10.1111/imm.13063. Immunology. 2019. PMID: 31013364 Free PMC article.
-
Acute pyelonephritis in pregnancy and plasma syndecan-1: evidence of glycocalyx involvement.J Matern Fetal Neonatal Med. 2023 Dec;36(1):2155041. doi: 10.1080/14767058.2022.2155041. J Matern Fetal Neonatal Med. 2023. PMID: 36642424 Free PMC article.
-
Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.FASEB J. 2009 Nov;23(11):3906-16. doi: 10.1096/fj.09-134643. Epub 2009 Aug 10. FASEB J. 2009. PMID: 19667120 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous